Dr. Reddy's Laboratories Ltd. closed 15.86% below its 52-week high of 1,420.20 rupees, which the company reached on August 21st.

Welcome to the Dr Reddys Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent ...

Dr. Reddy's Lab is poised to witness crosswinds from a drop in revenue from the patent expiration of Revlimid and increased ...

AM(IST)on Friday in an upbeat market. Biocon Ltd.(up 1.88 per cent), Zydus Lifesciences Ltd.(up 1.29 per cent), Dr. Reddy's ...

While Budget 2025 is expected to bring refinements that could further elevate certain industries, a critical shift in the ...

Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...

Asian equities traded in the US as American depositary receipts were sharply higher Thursday morning, rising 1.61% to 2,174.43 on the S&P Asia 50 ADR Index. From North Asia, the gainers were led by ...

Dr. Reddy's Laboratories Ltd. is a Public Limited Listed company incorporated on 24/02/1984 and has its registered office in the State of Telangana, India. Company's Corporate Identification ...

Nifty 50 was trading at 23249.50 (0.37%). Today Nifty 50 has been trading in the range of 23322.05 to 23139.20. Nifty futures ...

Salaried taxpayers hope Budget 2025 will see some major taxation reforms, including much-needed tax relief for them, higher ...

The global aspirin drug market is poised for substantial growth over the next decade, with its value expected to increase ...